5nance5nance
5nance5nance
HomeScreens
LOGINGET FREE ACCOUNT

Concord Biotech Ltd.

•
concordbiotech.comBSE: 543960NSE: CONCORDBIO
Market Cap₹ 15,324 Cr.
Current Price
High / Low₹ 1,704 / 987
Stock P/E54.4
Book Value₹ 199
Price to Book5.26
Dividend Yield0.52 %
ROCE18.4 %
ROE13.7 %
Face Value₹ 1

Add ratio to table

ABOUT

AI Sector View

AI GENERATED

Healthcare

Buy

This stance relies on proxies and positioning because no direct pharma-export or healthcare operating series exists in the dataset. The depreciated currency at 95.23 (Sep/26) can support export earnings, inflation at 4.45% (Jul/26) is manageable for a defensive sector, and consumer spending remains large at INR 44743 billion (Jun/26). Strong FPI inflow of INR 10620 crore over 3 months to 2026-08-31 from INR -11381 crore in the prior 3 months adds a real sector-specific tailwind, but confidence stays capped because the fundamental drivers are indirect proxies.

Confidence
50%
View full sector analysis →

PROS

  • Company is almost debt free
  • Company has a healthy return on capital (ROCE) of 25.7%
  • Latest quarter profit grew 43.7% YoY, showing strong momentum
  • Company has been maintaining a healthy dividend payout of 30.0%
  • Company has a consistent dividend-paying track record
  • Company generates healthy free cash flow

CONS

  • Recent results are weak - TTM profit is down 23.3% versus prior year
  • Company has delivered a poor profit growth of 2.3% over past five years
  • Operating margins have contracted to 35.7% from 45.0%
  • Stock is trading at 5.3x its book value
  • Expensive relative to growth - PEG of 16.0
  • Inventory has been piling up - inventory days up from 68 to 98

* The pros and cons are machine generated based on quantitative rules.

Peer comparison

HealthcareHealthcarePharmaceuticals & Drugs
Part ofNIFTY TOTAL MKTNIFTY 500NIFTY SMLCAP 250
S.No.Name
1.SUNPHARMA1868.5037.06448315.740.862901.2326.5315299.8810.9819.1128.81
2.DIVISLAB9482.7586.06251737.220.32902.0065.503080.0027.8021.5140.75
3.TORNTPHARM4931.9086.01187593.620.77566.003.284921.0057.3219.2733.81
4.ZYDUSLIFE1129.0024.95112618.180.09990.20-34.908017.0023.9721.3924.54
5.CIPLA1368.0032.79110515.040.95785.55-39.187119.284.1316.0016.73
6.LAURUSLABS1933.2595.54104455.860.103620.702139.4220263.101191.0018.2031.50
7.AUROPHARMA1690.0026.1997238.860.241032.0325.229150.3517.4412.7620.54
8.LUPIN2092.0017.3095660.020.861416.9816.018276.8934.2828.8629.59
9.DRREDDY1143.2029.6195420.610.70435.60-69.108099.80-5.2113.7510.63
10.MANKIND2266.0045.8293596.020.04574.0929.124030.5912.8913.2426.30
11.GLENMARK2439.5538.2968850.120.10482.83927.884018.4831.3520.3520.03
12.CONCORDBIO1464.8055.6515324.180.5257.7030.96257.4926.2318.0432.49
Detailed Comparison with:

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
195262241319216310244430204247278326261
123143135185135174146239143157176204191
Operating Profit721191061348113798190619110212269
OPM %37.03%45.43%43.99%42.10%37.66%44.06%40.11%44.30%30.10%36.65%36.75%37.55%26.53%
788111010159141371613
Interest1100000000000
Depreciation13131414131313151818191918
Profit before Tax65113100131781339918557869011882
Tax %25.44%25.35%25.51%25.74%25.50%25.95%25.40%23.32%25.63%26.45%24.93%23.96%25.56%
Net Profit488475975899741424363689061
4.638.087.139.295.579.437.0813.574.076.016.488.605.85

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
3223404365126177138531,0171,2001,0551,112
156194255308289439505585693678727
Operating Profit166145181205328274349432507377384
OPM %51.46%42.77%41.45%39.92%53.15%38.42%40.86%42.50%42.23%35.74%34.57%
1018173114233534444949
Interest111116103110
Depreciation1518192128505454547475
Profit before Tax159144178213313241320409496351376
Tax %31.65%30.40%33.46%20.86%24.85%25.95%25.60%25.53%24.79%25.09%25.11%
Net Profit109100118169235179238305373263282
EPS114.41105.66124.48177.6622.5017.0722.7629.1335.6525.17—
Dividend Payout %23.69%25.08%24.90%3.38%29.97%27.27%30.01%30.04%30.01%30.00%—

COMPOUNDED SALES GROWTH

10 Years:
14%
5 Years:
11%
3 Years:
7%

COMPOUNDED PROFIT GROWTH

10 Years:
12%
5 Years:
2%
3 Years:
3%

STOCK PRICE CAGR

10 Years:
—
5 Years:
—
3 Years:
13%
1 Year:
-13%

RETURN ON EQUITY

10 Years:
21%
5 Years:
19%
3 Years:
19%
Last Year:
14%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Corporate actions

2026

Jul 24

₹ 7.55

Rs.7.5500 per share(755%)Final Dividend

2025

Sep 3

₹ 10.70

Rs.10.7000 per share(1070%)Final Dividend

2024

Jun 21

₹ 8.75

Rs.8.7500 per share(875%)Dividend

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital10101010101010101010
5155856737619901,0981,2821,5151,8022,009
1913038886131210
Trade Payables2939337146839494113101
4138441691792519778107115
Total Liabilities6136867601,0491,3131,5031,5151,6992,0342,237
182189230240546573593575795786
Capital Work in Progress931914118741732115078
15415122919914274138244335488
617192111154195212208240326
0000000350522461
Cash & Bank12436189434719
206269186355393497355649289
Total Assets6136867601,0491,3131,5031,5151,6992,0342,237

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
125129219204242268316265245264
Cash from Investing-127-42-116-113-195-112-158-155-160-142
Cash from Financing39-37-45-4331-100-85-99-99-115
002-13-4312-147

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026

Shareholding Pattern

Numbers in percentages

Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
44.0844.0844.0844.0844.0844.0844.0844.0844.08
7.118.108.339.359.108.037.587.797.53
10.359.829.589.158.849.549.579.229.37
Government0.000.000.000.000.000.000.000.000.00
38.4638.0038.0037.4237.9638.3438.7738.9039.03

Documents

Corporate disclosures, annual reports, credit ratings, and concall transcripts

2026-08-21
Analysts/Institutional Investor Meet/Con. Call Updates

2026-08-21 - Concord Biotech Limited has informed the Exchange about Schedule of meet

2026-08-07
Analysts/Institutional Investor Meet/Con. Call Updates

2026-08-07 - Concord Biotech Limited has informed the Exchange about Transcript

2026-08-03
Analysts/Institutional Investor Meet/Con. Call Updates

2026-08-03 - Concord Biotech Limited has informed the Exchange about Link of Recording

2026-08-01
Analysts/Institutional Investor Meet/Con. Call Updates

2026-08-01 - Concord Biotech Limited has informed the Exchange about Presentation

2026-08-01
Shareholders meeting

2026-08-01 - Concord Biotech Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on July 31, 2026. Further, the company has informed the Exchange regarding voting results.

2026-08-01
Copy of Newspaper Publication

2026-08-01 - Concord Biotech Limited has informed the Exchange about Copy of Newspaper Publication

2026-07-31
Shareholders meeting

2026-07-31 - Concord Biotech Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on July 31, 2026

2026-07-31
Outcome of Board Meeting

2026-07-31 - Concord Biotech Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.

2026-07-28
Analysts/Institutional Investor Meet/Con. Call Updates

2026-07-28 - Concord Biotech Limited has informed the Exchange about Schedule of meet

News

Recent coverage and analyst commentary for CONCORDBIO

Loading news…

🤖

AI Stock Analyst

Concord Biotech Ltd.

🔒

Sign in to Chat with AI

Log in with your 5nance account to ask institutional questions about performance, financials, and outlook.

✨ Sign In to Chat

Free 5nance Account

5nance5nance

Stock analysis and screening tool

5nanceAI © 2020-2026

Made with ❤️ in India.

Data provided by Accord Fintech

Terms & Privacy.

Product

PremiumWhat's new?Learn

Team

About usSupport

Theme

5nance5nance

Product

PremiumWhat's new?Learn

Team

About usSupport

Theme

5nanceAI © 2020-2026

Data provided by Accord Fintech

Made with ❤️ in India.

HomeScreens
Login